Sopharma AD-Sofia (FRA:3JR) E10: €0.28 (As of Mar. 2026)


FRA:3JR Sopharma AD-Sofia FRA:3JR
65 GF Score
Price €1.84
GF Value €3.02
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Sopharma AD-Sofia E10?

Sopharma AD-Sofia FRA:3JR +6.36% 65 E10 is €0.28 as of Mar. 2026. GuruFocus rates FRA:3JR with a GF Score™ of 65/100 and a GF Value™ of €3.02 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sopharma AD-Sofia's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.28 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sopharma AD-Sofia was 5.50% per year. The lowest was 5.50% per year. And the median was 5.50% per year.

As of today (2026-07-04), Sopharma AD-Sofia's current stock price is €1.84. Sopharma AD-Sofia's E10 for the quarter that ended in Mar. 2026 was €0.28. Sopharma AD-Sofia's Shiller PE Ratio of today is 6.57.

During the past 13 years, the highest Shiller PE Ratio of Sopharma AD-Sofia was 30.42. The lowest was 5.91. And the median was 20.43.


Sopharma AD-Sofia  (FRA:3JR) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sopharma AD-Sofia's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1.84/0.28
=6.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sopharma AD-Sofia was 30.42. The lowest was 5.91. And the median was 20.43.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sopharma AD-Sofia E10 Related Terms


Sopharma AD-Sofia E10 Historical Data

* Premium members only.

The historical data trend for Sopharma AD-Sofia's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma AD-Sofia E10 Chart

Sopharma AD-Sofia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.10 0.09 0.09 0.20

Sopharma AD-Sofia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.08 0.20 0.20 0.28

FRA:3JR vs MCK, CAH, COR: E10 Comparison

For the Medical Distribution subindustry, Sopharma AD-Sofia's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia Shiller PE Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Shiller PE Ratio falls into.


FRA:3JR
65GF Score
Sopharma AD-Sofia FRA:3JR
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma AD-Sofia E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sopharma AD-Sofia's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.06/330.2130*330.2130
=0.060

Current CPI (Mar. 2026) = 330.2130.

Sopharma AD-Sofia Quarterly Data

per share eps CPI Adj_EPS
201603 0.041 238.132 0.057
201606 0.063 241.018 0.086
201609 0.021 241.428 0.029
201612 0.076 241.432 0.104
201703 0.067 243.801 0.091
201706 0.047 244.955 0.063
201709 0.015 246.819 0.020
201712 -0.046 246.524 -0.062
201803 0.050 249.554 0.066
201806 0.034 251.989 0.045
201809 0.025 252.439 0.033
201812 0.006 251.233 0.008
201903 0.127 254.202 0.165
201906 0.029 256.143 0.037
201909 0.045 256.759 0.058
201912 0.216 256.974 0.278
202006 0.000 257.797 0.000
202009 0.005 260.280 0.006
202012 0.032 260.474 0.041
202103 0.071 264.877 0.089
202106 0.057 271.696 0.069
202109 0.073 274.310 0.088
202112 0.157 278.802 0.186
202203 0.087 287.504 0.100
202206 0.097 296.311 0.108
202209 0.102 296.808 0.113
202212 0.004 296.797 0.004
202303 0.132 301.836 0.144
202306 0.127 305.109 0.137
202309 0.046 307.789 0.049
202312 0.046 306.746 0.050
202403 0.117 312.332 0.124
202406 0.050 314.175 0.053
202409 0.041 315.301 0.043
202412 0.036 315.605 0.038
202503 0.000 319.799 0.000
202506 0.089 322.561 0.091
202509 0.040 324.800 0.041
202512 0.018 324.054 0.018
202603 0.060 330.213 0.060

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.28 mean?
Sopharma AD-Sofia (FRA:3JR) has a E10 of €0.28 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sopharma AD-Sofia and its competitors.
Is Sopharma AD-Sofia's E10 too high?
Sopharma AD-Sofia's current E10 is €0.28. Overall, Sopharma AD-Sofia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sopharma AD-Sofia's E10 compare to MCK and CAH?
Sopharma AD-Sofia's E10 of €0.28 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Distribution company?
A good E10 depends on the Medical Distribution industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sopharma AD-Sofia and its competitors. Sopharma AD-Sofia's current E10 is €0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma AD-Sofia stock overvalued right now?
Based on GuruFocus' analysis, Sopharma AD-Sofia (FRA:3JR) is currently considered Possible Value Trap. The stock's GF Value™ is €3.02, compared to a current price of €1.84 — trading 39.1% below its estimated fair value. The current E10 is €0.28. Sopharma AD-Sofia's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Sopharma AD-Sofia (FRA:3JR), the current E10 is €0.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sopharma AD-Sofia (FRA:3JR) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued. The current stock price of €1.84 is trading 39.1% below its estimated GF Value™ of €3.02. GuruFocus considers Sopharma AD-Sofia to be Possible Value Trap.

Key valuation signals for FRA:3JR:

  • E10: €0.28
  • GF Value™: €3.02 vs. price of €1.84 (39.1% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the FRA:3JR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sopharma AD-Sofia Business Description

Other Exchanges SPH:PolandSFA:Bulgaria
Address 5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 12, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
65GF Score

Get the complete analysis for FRA:3JR

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.84
Price
€3.02
GF Value